Social Media Ideas for Eribulin Mesylate

FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer

By: Sabrina Serani From; targetedonc.com The FDA has approved an abbreviated new drug application (ANDA) for generic eribulin mesylate injection, offering a new therapeutic option...

<![CDATA[Ibrance Wins FDA Approval for HR-Positive, HER2-Positive Metastatic Breast Cancer Maintenance Therapy]]>

<![CDATA[FDA Expands Enhertu in Early HER2-Positive Breast Cancer]]>

<![CDATA[FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer]]>

NATCO Pharma Stock in Focus After Receiving USFDA Approval For Cancer Drug With Lupin

Synopsis: NATCO Pharma and its alliance partner Lupin have received USFDA approval for Eribulin Mesylate Injection, a generic version of Eisai’s Halaven used in the treatment of me...

EMA Recommends Generic for Advanced/Metastatic Breast Cancer

By: Sophie Cousins From: medscape.com The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting a marketing authorisation for Pa...

<![CDATA[FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhi...

<![CDATA[Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer]...